Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
- Citation:
- J Natl Cancer Inst vol 99 (9) 672-9
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- CA-25224, CA-35090, CA-35101, CA-35103, CA-35113, CA-35119, CA-35195, CA-35267, CA-35269, CA-35415, CA-35431, CA-35448, CA-37417, CA-52352, CA-60276, CA-63848, CA-63849, U-10 CA-37404
- Corr. Author:
- Authors:
- Debra L Barton Donald B Wender Jeff A Sloan Robert J Dalton Ernie P Balcueva Pamela J Atherton Albert M Bernath Wanda L DeKrey Tim Larson James D Bearden Paul C Carpenter Charles L Loprinzi
- Networks:
- Study
- NCCTG-N02C3
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Administration, Cutaneous, Adult, Aged, Female, Humans, Interviews as Topic, Libido, Middle Aged, Neoplasms, Placebos, Sexual Behavior, Surveys and Questionnaires, Survivors, Testosterone, Treatment Outcome